ROMMEL CO: Open Payments
NPI 1548649924 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,341 in 59 payments from 13 companies in 2025. Trend: 2023 $1,607 · 2024 $1,363 · 2025 $1,341
Food & beverage: $1,341
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $246 |
| AstraZeneca Pharmaceuticals LP | 10 | $243 |
| PFIZER INC. | 10 | $212 |
| Astellas Pharma US Inc | 4 | $135 |
| ABBVIE INC. | 5 | $111 |
| Lilly USA, LLC | 5 | $102 |
| Novo Nordisk Inc | 3 | $67 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Merck Sharp & Dohme LLC | 2 | $50 |
| Sumitomo Pharma America, Inc. | 2 | $50 |
Products named: NURTEC ODT, Veozah, KRYSTEXXA, OTEZLA, MOUNJARO, BREZTRI, VRAYLAR, TRELEGY ELLIPTA.
Industry payments across NV — which companies pay providers there.
